|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for (release of) credit losses | |||||
| Amortization (accretion) of deferred charges and fees, net | |||||
| Depreciation (accretion), and amortization, net | |||||
| Bank owned life insurance income | |||||
| Share-based compensation and other share-based activity | |||||
| Change in accrued interest receivable | |||||
| Deferred income tax expense | |||||
| Change in loans held for sale | |||||
| Change in other assets, net | |||||
| Change in other liabilities, net | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Origination of loans | |||||
| Proceeds from principal payments of loans | |||||
| Purchase of loans | |||||
| Proceeds from calls/maturities of securities available for sale | |||||
| Purchase of securities available for sale | |||||
| Proceeds from sales of securities | |||||
| Proceeds from calls/maturities of securities held to maturity | |||||
| Purchase of securities held to maturity | |||||
| Death benefit on bank-owned life insurance | |||||
| Redemption on bank-owned life insurance | |||||
| (Purchase) redemption of FHLB of Boston stock | |||||
| Purchase of banking premises and equipment | |||||
| Net cash acquired in business combinations | |||||
| Net cash provided by (used in) investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Change in demand, interest-bearing, money market and savings accounts | |||||
| Change in certificates of deposit | |||||
| Change in borrowings | |||||
| Cash dividends paid on common stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes | |||||
| Significant non-cash transactions | |||||
| Common Stock issued to shareholders due to merger | |||||
| Fair value of assets acquired, net of cash acquired | |||||
| Fair value of liabilities assumed | |||||
Loading...